[{"address1": "3710 \u2013 33rd Street NW", "city": "Calgary", "state": "AB", "zip": "T2L 2M1", "country": "Canada", "phone": "403 455 7727", "website": "https://www.xortx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "XORTX Therapeutics Inc., a late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat gout and progressive kidney disease. Its drug development programs include XRx-026, which is in the third phase for the treatment of gout; XRx-008, which is in the second phase to treat autosomal dominant polycystic kidney disease; XRx-101, which is in the second phase to treat acute kidney injury associated with respiratory virus infection; and XRX-225, which is in the preclinical stage for the treatment of type 2 diabetic nephropathy. It has a license agreement with the University of Florida Research Foundation, Inc. for the use of uric acid lowering agent to treat insulin resistance. The company is based in Calgary, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Allen Warren Davidoff Ph.D.", "age": 64, "title": "Founder, CEO, President & Director", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 391655, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael Scott Bumby D.V.M., M.B.A.", "age": 60, "title": "Chief Financial Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 6515, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen  Haworth M.D., MRCP", "age": 74, "title": "Chief Medical Officer", "yearBorn": 1950, "fiscalYear": 2024, "totalPay": 110445, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stacy  Evans M.B.A., M.D.", "age": 50, "title": "Chief Business Officer", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 157500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Nick  Rigopoulos", "title": "Director of Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  Sans M.B.A., Ph.D.", "age": 54, "title": "Director of Corporate Development", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  MacDonald Ph.D.", "age": 61, "title": "Consultant of Clinical Operations", "yearBorn": 1963, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Charlotte  May", "title": "Corporate Secretary", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.8584, "open": 0.83, "dayLow": 0.7993, "dayHigh": 0.83, "regularMarketPreviousClose": 0.8584, "regularMarketOpen": 0.83, "regularMarketDayLow": 0.7993, "regularMarketDayHigh": 0.83, "payoutRatio": 0.0, "beta": -0.05, "forwardPE": -0.47904193, "volume": 46655, "regularMarketVolume": 46655, "averageVolume": 119136, "averageVolume10days": 32380, "averageDailyVolume10Day": 32380, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 4169774, "fiftyTwoWeekLow": 0.661, "fiftyTwoWeekHigh": 2.51, "allTimeHigh": 495.72, "allTimeLow": 0.661, "fiftyDayAverage": 0.82428, "twoHundredDayAverage": 0.942025, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 3186770, "profitMargins": 0.0, "floatShares": 5069038, "sharesOutstanding": 5212218, "sharesShort": 19700, "sharesShortPriorMonth": 67518, "sharesShortPreviousMonthDate": 1755216000, "dateShortInterest": 1757894400, "sharesPercentSharesOut": 0.0038, "heldPercentInsiders": 0.02632, "heldPercentInstitutions": 0.046430003, "shortRatio": 0.42, "shortPercentOfFloat": 0.0039, "impliedSharesOutstanding": 5429809, "bookValue": 0.536, "priceToBook": 1.4925373, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -1880849, "trailingEps": -0.46, "forwardEps": -1.67, "lastSplitFactor": "1:9", "lastSplitDate": 1699920000, "enterpriseToEbitda": -1.248, "52WeekChange": -0.5121951, "SandP52WeekChange": 0.1529237, "quoteType": "EQUITY", "currentPrice": 0.8, "targetHighPrice": 13.814374, "targetLowPrice": 13.814374, "targetMeanPrice": 13.814374, "targetMedianPrice": 13.814374, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 1, "totalCash": 1063477, "totalCashPerShare": 0.204, "ebitda": -2552788, "totalDebt": 80473, "quickRatio": 1.51, "currentRatio": 1.777, "debtToEquity": 3.963, "returnOnAssets": -0.42154998, "returnOnEquity": -0.79440004, "freeCashflow": -2797770, "operatingCashflow": -3075508, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "XRTX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "XORTX Therapeutics Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1632403800000, "postMarketChangePercent": 0.0, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1758924505, "regularMarketTime": 1758916800, "exchange": "NCM", "messageBoardId": "finmb_259860883", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -6.8033524, "regularMarketPrice": 0.8, "longName": "XORTX Therapeutics Inc.", "postMarketPrice": 0.8, "postMarketChange": 0.0, "regularMarketChange": -0.058399975, "regularMarketDayRange": "0.7993 - 0.83", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 119136, "fiftyTwoWeekLowChange": 0.139, "fiftyTwoWeekLowChangePercent": 0.21028744, "fiftyTwoWeekRange": "0.661 - 2.51", "fiftyTwoWeekHighChange": -1.71, "fiftyTwoWeekHighChangePercent": -0.6812749, "fiftyTwoWeekChangePercent": -51.219513, "earningsTimestamp": 1755057600, "earningsTimestampStart": 1763037000, "earningsTimestampEnd": 1763037000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.46, "epsForward": -1.67, "epsCurrentYear": -1.307, "priceEpsCurrentYear": -0.61208874, "fiftyDayAverageChange": -0.024280012, "fiftyDayAverageChangePercent": -0.029456023, "twoHundredDayAverageChange": -0.142025, "twoHundredDayAverageChangePercent": -0.15076563, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-10-13", "averageAnalystRating": "1.0 - Strong Buy", "cryptoTradeable": false, "displayName": "XORTX Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-09-27"}]